Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco. It offers products in various therapeutic areas, including allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and other generic drugs. The company also provides its products in various forms, such as tablets, capsules, pouches, syrups, suspensions, powders, collyriums, suppositories, creams and pomades, injectable solutions, and self-injectable syringes. In addition, it imports licensed medicines and dental products, as well as biotechnology products; and manufactures medicines under other labels. The company exports its products to Europe, Maghreb, Sub-Saharan Africa, and the Persian Gulf. Société de Therapeutique Marocaine S.A. was founded in 1976 and is based in Bouskoura, Morocco.
Metrics to compare | SOT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOTPeersSector | |
---|---|---|---|---|
P/E Ratio | 24.4x | 18.7x | −0.7x | |
PEG Ratio | 4.40 | 0.07 | 0.00 | |
Price / Book | 4.5x | 1.9x | 2.6x | |
Price / LTM Sales | 2.6x | 1.8x | 3.2x | |
Upside (Analyst Target) | - | 14.9% | 44.5% | |
Fair Value Upside | Unlock | 19.7% | 6.6% | Unlock |